The results of this cohort study suggest that individuals with type 2 diabetes who initiated treatment with empagliflozin or ...

Big Pharma is again raising the prices for key medications that could save the lives of millions in Georgia and there are still more hikes to come.

No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

Taken at face value, the results would suggest that the three SGLT2 inhibitors are "virtually identical," according to ...

A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

Next up, Tremfya made a triumphant return to the 2024 roundup after falling off the rankings in 2023. The med's return came ...

The Biden Administration enacted a slew of prescription drug cost reductions for seniors and citizens on Medicaid. The ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

The internet is full of false claims. Columnist Sam Kirton shares why fact-checking is important, particularly for the rare disease world.

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...